Of particular note was a tumour-specific TP53 variant present at baseline, which was absent in samples B and C, but re-emerged at a high frequency in sample D – presumably a resistance clone that was dormant for a prolonged period of time (Figure 4C). Here, TP53 is linked to neoplasm.